Atovaquone Suspension
Product Images NDC 69452-252

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 69452-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image0001

Label for Atovaquone Oral Suspension USP 750 mg/5 mL, an oral suspension prescription drug by Bionpharma Inc. The label includes dosage strength, volume of 210 mL, storage instructions, and distribution address. It also displays the product NDC 69452-252-87 and warnings such as shaking gently before use and confirming the tamper-evident seal.*

FDA Label Image

Image0002

The packaging label for Atovaquone Oral Suspension, USP, 750 mg/5 mL, by Bionpharma Inc. The label indicates a 210 mL oral suspension bottle, with usage instructions and storage conditions. Warnings include shaking gently before use and not using if the tamper-evident seal is broken or missing. The label also includes the product NDC 69452-252-87.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Atovaquone, showing its molecular framework with distinct aromatic rings and a chlorine atom attached, representing the active ingredient in the Atovaquone oral suspension labeled by Bionpharma Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.